Fertility Preservation in Young Women With Cancer: an International Registration Study From the International Network on Cancer, Infertility and Pregnancy (INCIP)

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

The researchers aim to record the incidence, treatment and long term follow up of fertility preserving cancer treatment. Both the oncological and fertility outcome are recorded. Study population: All patients with a cancer for whom a fertility preserving cancer treatment is applied. The results of the study population are compared to young women undergoing standard cancer treatment.

Eligibility
Participation Requirements
Sex: Female
Maximum Age: 40
Healthy Volunteers: f
View:

• Young women who want to preserve their fertility during cancer treatment. Patients need to give their signed and written informed consent to participate in the study.

Locations
Other Locations
Belgium
UZ Gasthuisberg, Katholieke Universiteit Leuven
RECRUITING
Leuven
Netherlands
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
RECRUITING
Amsterdam
Contact Information
Primary
Katrien Van Tornout
katrien.vantornout@uzleuven.be
+3216342876
Time Frame
Start Date: 2017-05-23
Estimated Completion Date: 2032-07
Participants
Target number of participants: 2000
Treatments
Study group
control group
Related Therapeutic Areas
Sponsors
Collaborators: Medical University of Vienna, Haukeland University Hospital, NKI-AvL, Oslo University Hospital, N.N. Blokchin NMRCO, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Leads: University Hospital, Gasthuisberg

This content was sourced from clinicaltrials.gov